Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Cardlytics, Inc. market cap for the quarter ending 2026-07-31 was $22.11M, a 79.54% decline year-over-year.
Cardlytics, Inc. market cap for the quarter ending 2026-06-30 was $24.53M, a 70.91% decline year-over-year.
Cardlytics, Inc. market cap for the quarter ending 2026-04-30 was $52.09M, a 93.11% decline year-over-year.
Cardlytics, Inc. market cap for the quarter ending 2026-03-31 was $57.51M, a 93.83% decline year-over-year.
Cardlytics, Inc. market cap for fiscal 2026 was $22.11M.
Cardlytics, Inc. market cap for fiscal 2025 was $6.3M, a 99.67% decline from fiscal 2024.
Cardlytics, Inc. market cap for fiscal 2024 was $1.9B, a 48.03% decline from fiscal 2023.
Cardlytics, Inc. market cap for fiscal 2023 was $3.66B.